TRV GP IV, LLC - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 113 filers reported holding FULCRUM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.4%.

Quarter-by-quarter ownership
TRV GP IV, LLC ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,403,604
+34.5%
2,343,1540.0%3.92%
-43.9%
Q2 2023$7,732,408
+15.8%
2,343,1540.0%6.99%
+46.4%
Q1 2023$6,677,989
-60.9%
2,343,1540.0%4.77%
-34.2%
Q4 2022$17,058,161
-10.0%
2,343,1540.0%7.25%
-34.5%
Q3 2022$18,956,000
+65.1%
2,343,1540.0%11.08%
+46.7%
Q2 2022$11,481,000
-79.3%
2,343,1540.0%7.55%
-62.8%
Q1 2022$55,416,000
+33.7%
2,343,1540.0%20.30%
+70.3%
Q4 2021$41,450,000
-37.3%
2,343,1540.0%11.92%
-20.5%
Q3 2021$66,100,000
+169.2%
2,343,1540.0%15.00%
+28.3%
Q2 2021$24,556,000
-11.0%
2,343,1540.0%11.69%
+15.0%
Q1 2021$27,602,000
+0.6%
2,343,1540.0%10.17%
+15.5%
Q4 2020$27,438,000
+47.7%
2,343,1540.0%8.80%
+37.6%
Q3 2020$18,581,000
-56.6%
2,343,1540.0%6.40%
-67.6%
Q2 2020$42,856,000
+53.2%
2,343,1540.0%19.74%
-22.8%
Q1 2020$27,977,000
-28.2%
2,343,1540.0%25.58%
+5.2%
Q4 2019$38,990,000
+150.6%
2,343,1540.0%24.31%
+52.7%
Q3 2019$15,559,0002,343,15415.92%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
TRV GP III, LLC 3,962,202$19,415,0007.94%
TRV GP IV, LLC 2,343,154$11,481,0007.55%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 949$193,741,0002.02%
Logos Global Management LP 1,950,000$9,555,0001.75%
COWEN AND COMPANY, LLC 2,385,885$11,691,0001.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,355,624$16,443,0000.62%
ACUTA CAPITAL PARTNERS, LLC 200,000$980,0000.55%
RTW INVESTMENTS, LP 3,961,194$19,410,0000.50%
Parkman Healthcare Partners LLC 262,689$1,287,0000.47%
Deep Track Capital, LP 1,000,000$4,900,0000.32%
View complete list of FULCRUM THERAPEUTICS INC shareholders